Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-02-17 | 2022-03-24 | 155137 |
TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-02-17 | 2022-03-24 | 155155 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155183 |
TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-03-04 | 2022-03-24 | 156064 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT | Resolved | 2022-03-04 | 2022-03-24 | 156070 |
TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-10 | 2022-03-24 | 156407 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2022-03-26 | 120253 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2021-09-09 | 2022-03-26 | 145449 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-03-24 | 2022-03-26 | 157274 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-02-24 | 2022-04-01 | 155557 |
TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2022-02-10 | 2022-04-01 | 154717 |
TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-01-20 | 2022-04-01 | 153183 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-02-24 | 2022-04-09 | 155560 |
TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2022-03-24 | 2022-04-09 | 157247 |
RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2022-03-24 | 2022-04-09 | 157250 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-03-24 | 2022-04-09 | 157268 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-03-24 | 2022-04-09 | 157271 |
ACT PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-03-12 | 2022-04-21 | 108625 |
TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2021-03-04 | 2022-04-21 | 135138 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |